0001209191-22-016527.txt : 20220304 0001209191-22-016527.hdr.sgml : 20220304 20220304205845 ACCESSION NUMBER: 0001209191-22-016527 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220302 FILED AS OF DATE: 20220304 DATE AS OF CHANGE: 20220304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wassil Jim CENTRAL INDEX KEY: 0001813798 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39323 FILM NUMBER: 22716016 MAIL ADDRESS: STREET 1: C/O VAXCYTE, INC. STREET 2: 353 HATCH DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxcyte, Inc. CENTRAL INDEX KEY: 0001649094 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464233385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 825 INDUSTRIAL ROAD, STE. 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-837-0111 MAIL ADDRESS: STREET 1: 825 INDUSTRIAL ROAD, STE. 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: SutroVax, Inc. DATE OF NAME CHANGE: 20150724 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-02 0 0001649094 Vaxcyte, Inc. PCVX 0001813798 Wassil Jim C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 0 1 0 0 Chief Operating Officer Common Stock 2022-03-02 4 A 0 25000 0.00 A 42944 D Stock Option (right to buy) 24.79 2022-03-02 4 A 0 100000 0.00 A 2032-03-01 Common Stock 100000 100000 D Stock Option (right to buy) 24.79 2022-03-02 4 A 0 150000 0.00 A 2032-03-01 Common Stock 150000 150000 D Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2022 and 12.5% of the shares every six months thereafter. 12/48 of shares subject to the option vest on February 15, 2023, and 1/48 of the shares vest monthly thereafter. 1/48 of shares subject to the option vest on April 2, 2022, and 1/48 of the shares vest monthly thereafter. /s/ Ron Metzger, Attorney-in-Fact 2022-03-04